These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23607456)

  • 21. An endogenous dopaminergic tone acting on dopamine D3 receptors may be involved in diurnal changes of tuberoinfundibular dopaminergic neuron activity and prolactin secretion in estrogen-primed ovariectomized rats.
    Liang SL; Pan JT
    Brain Res Bull; 2012 Feb; 87(2-3):334-9. PubMed ID: 22155687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome].
    Wu X; Gu Q; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):489-91. PubMed ID: 9639745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the renin--aldosterone axis and of prolactin secretion during pregnancy by L-dopa.
    Kaulhausen H; Oney T; Leyendecker G
    Br J Obstet Gynaecol; 1982 Jun; 89(6):483-8. PubMed ID: 7044409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of experimentally induced hyperprolactinemia on growth hormone secretion.
    Esquifino AI; Fernández-Ruiz JJ; Cebeira M; Agrasal C; Tresguerres JA; Ramos JA
    Rev Esp Fisiol; 1987 Dec; 43(4):463-8. PubMed ID: 3448711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS; Jacobs LS
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
    Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
    Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of exposure to plant-derived odorants on behavior and the concentration of stress-related hormones in steers isolated under a novel environment.
    Sutoh M; Ito S; Kasuya E; Yayou K
    Anim Sci J; 2013 Feb; 84(2):159-64. PubMed ID: 23384358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebroventricularly administered oxytocin attenuated cortisol secretion, but not behavioral responses, during isolation in Holstein steers.
    Yayou K; Ito S; Kasuya E; Sutoh M; Ohkura S; Okamura H
    J Vet Med Sci; 2008 Jul; 70(7):665-71. PubMed ID: 18685237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of L-dopa on expression of prolactin and synaptotagmin IV in 17-beta-estradiol-induced prolactinomas of ovariectomized hemiparkinsonian rats.
    Zorovic M; Kolmančič K; Živin M
    Bosn J Basic Med Sci; 2021 Dec; 21(6):702-711. PubMed ID: 33823126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of prolactin-releasing response to salsolinol in vivo in cattle.
    Hashizume T; Sawada T; Yaegashi T; Saito H; Ahmed AE; Goto Y; Nakajima Y; Jin J; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2010 Jul; 39(1):21-5. PubMed ID: 20172684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia.
    Kelley SR; Kamal TJ; Molitch ME
    Am J Physiol; 1996 Jan; 270(1 Pt 1):E96-100. PubMed ID: 8772480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sulpiride on plasma prolactin in rats.
    Iwasaki Y; Kato Y; Chihara K; Ohgo S; Maeda K
    Neuroendocrinology; 1976; 21(3):267-74. PubMed ID: 1018732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short prolactin profile for monitoring treatment in BH4 deficiency.
    Porta F; Ponzone A; Spada M
    Eur J Paediatr Neurol; 2015 May; 19(3):360-3. PubMed ID: 25707872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of L-dopa on plasma levels of parathyroid hormone in calves.
    Blum JW; Schams D; Born W; Da Prada M
    J Endocrinol Invest; 1982; 5(5):311-4. PubMed ID: 7153475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of administration of dopamine and L-DOPA to dogs on their plasma level of dopamine sulfate.
    Oka M; Ishimura Y; Tsunematsu T; Minakuchi K; Ohuchi T; Matsumoto K
    Biochem Pharmacol; 1987 Oct; 36(19):3205-8. PubMed ID: 3663235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No evidence for a peripheral effect of L-DOPA on plasma prolactin in the rat.
    Mattheij JA; Brouwer GM; Hanstede JG; Swarts JJ
    Life Sci; 1982 Aug; 31(9):915-21. PubMed ID: 7176820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin inhibition test with L-dopa: decrease and restoration of plasma prolactin levels in the rat by a peripheral process.
    van der Gugten AA; Sahuleka PC; van Galen GH; Kwa HG
    J Endocrinol; 1976 Mar; 68(3):369-81. PubMed ID: 1255091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.